{
  "id": "64144200201352f04a000043",
  "type": "yesno",
  "question": "Is anaphylaxis a results of mast cell activation?",
  "ideal_answer": "anaphylaxis is a result of mast cell activation.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29431885",
    "http://www.ncbi.nlm.nih.gov/pubmed/20678798",
    "http://www.ncbi.nlm.nih.gov/pubmed/17128671",
    "http://www.ncbi.nlm.nih.gov/pubmed/15025396",
    "http://www.ncbi.nlm.nih.gov/pubmed/19082920",
    "http://www.ncbi.nlm.nih.gov/pubmed/22794697",
    "http://www.ncbi.nlm.nih.gov/pubmed/15025392",
    "http://www.ncbi.nlm.nih.gov/pubmed/20519881",
    "http://www.ncbi.nlm.nih.gov/pubmed/35080312",
    "http://www.ncbi.nlm.nih.gov/pubmed/34292177",
    "http://www.ncbi.nlm.nih.gov/pubmed/27130857",
    "http://www.ncbi.nlm.nih.gov/pubmed/34867939",
    "http://www.ncbi.nlm.nih.gov/pubmed/23855441",
    "http://www.ncbi.nlm.nih.gov/pubmed/20526344",
    "http://www.ncbi.nlm.nih.gov/pubmed/2661436",
    "http://www.ncbi.nlm.nih.gov/pubmed/25841551",
    "http://www.ncbi.nlm.nih.gov/pubmed/31011586",
    "http://www.ncbi.nlm.nih.gov/pubmed/33832694",
    "http://www.ncbi.nlm.nih.gov/pubmed/24586553",
    "http://www.ncbi.nlm.nih.gov/pubmed/32276688",
    "http://www.ncbi.nlm.nih.gov/pubmed/28798744",
    "http://www.ncbi.nlm.nih.gov/pubmed/12209078",
    "http://www.ncbi.nlm.nih.gov/pubmed/27906487",
    "http://www.ncbi.nlm.nih.gov/pubmed/25240785",
    "http://www.ncbi.nlm.nih.gov/pubmed/33097573",
    "http://www.ncbi.nlm.nih.gov/pubmed/31690393",
    "http://www.ncbi.nlm.nih.gov/pubmed/26857018",
    "http://www.ncbi.nlm.nih.gov/pubmed/22744266",
    "http://www.ncbi.nlm.nih.gov/pubmed/24948367"
  ],
  "snippets": [
    {
      "text": "Mast cells are important effector cells in allergic inflammatory reactions. The aggregation of the high-affinity IgE receptor (FcepsilonRI) on the surface of mast cells initiates a complex cascade of signaling events that ultimately leads to the release of various mediators involved in allergic inflammation and anaphylactic reactions",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/19082920",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "During the IgE-mediated anaphylactic reaction mast cells release proteases such as tryptase, histamine and vasoactive mediators",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/17128671",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Histamine and other deleterious inflammatory mediators promote vascular permeability and smooth muscle contraction; they are readily released from sensitized mast cells and basophils challenged with antigen. Anaphylaxis may be triggered by a variety of antigens including insect and reptile venom, a variety of drugs, vaccines, and food",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23855441",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Earlier mast cells were only known for their important role in the type 1 allergic reactions (i.e. anaphylaxis or some contact hypersensitivity reactions) ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20678798",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anaphylaxis results from severe systemic mast cell activation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25841551",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In IgE-dependent and other examples of anaphylaxis, tissue mast cells and circulating basophilic granulocytes (basophils) are thought to represent major (if not the major) sources of the biologically active mediators that contribute to the pathology and, in unfortunate individuals, fatal outcome, of anaphylaxis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20519881",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Mast cell activation syndromes presenting as anaphylaxis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25841551",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "PURPOSE OF REVIEW: Mast cell activation syndrome (MCAS) and anaphylaxis are the result of a spontaneous or triggered pathological degranulation of mast cells (MCs) and might have as substrate normal or pathological MCs (increased burden, aberrant MCs or both).RECENT FINDINGS: This review summarizes the most recent evidence on immunoglobulin E (IgE)-mediated and non IgE-mediated mechanisms underlying MC activation and degranulation and highlights the importance of standa",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34292177",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Elevated mast cell mediators such as tryptase and histamine have been reported during episodes, and mast cells are considered the primary cells responsible for driving anaphylaxis in humans.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32276688",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In this chapter, we will describe the mechanisms of mast cell (and basophil) activation in anaphylaxis, with a focus on IgE-dependent activation, which is thought to be responsible for most examples of antigen-induced anaphylaxis in humans.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20519881",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anaphylaxis is a life-threatening syndrome resulting from the sudden release of mast cell- and basophil-derived mediators into the circulation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/12209078",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Some usual clinical manifestations in anaphylaxis, such as angioedema or hypotension, or other less common, such as metrorrhagia, may be explained by the direct effect of the activation of the coagulation and contact system driven by mast cell mediators.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28798744",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Idiopathic anaphylaxis involves mast cell activation (acutely elevated urine histamine or serum tryptase) and activated lymphocytes.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31690393",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "When there is activation of mast cells and basophils in anaphylaxis, chemical mediators are detectable.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31690393",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Systemic anaphylaxis arises when mast cells, possibly along with other cell types, are provoked to secrete mediators that evoke a systemic response.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15025392",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anaphylaxis results from the massive activation of the mast cells (MCs).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35080312",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Human mast cells, by elaborating vasoactive mediators and cytokines, are the primary effector cells of anaphylaxis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/15025396",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Although the mast cell is considered the major effector cell during acute allergic reactions, more recent studies indicate a potentially important and specific role for basophils and their migration which occurs rapidly upon allergen challenge in humans undergoing anaphylaxis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29431885",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Acute anaphylaxis to small molecule drugs is largely considered to be antibody-mediated with immunogloblin E (IgE) and mast cell activation being key.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34867939",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anaphylactic Degranulation of Mast Cells: Focus on Compound Exocytosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31011586",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Idiopathic Anaphylaxis: A Form of Mast Cell Activation Syndrome.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32276688",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": " A precondition for the unfolding of the anaphylactic shock is the secretion of inflammatory mediators from mast cells in response to an allergen, mostly through activation of the cells via the IgE-dependent pathway.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31011586",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " Beyond IgE-mediated activation of mast cells/basophils, further mechanisms are involved in the occurrence of anaphylaxis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28798744",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " When there is activation of mast cells and basophils in anaphylaxis, chemical mediators are detectable.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22794697",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Extensive activation of mast cells is the major switch that triggers systemic anaphylaxis, resulting in the subsequent release of anaphylactic mediators into circulation.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33097573",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ed in the amplification of the mast cell response during anaphylaxis are unclear. Mouse models of anaphylaxis demonstrate the critical involvement of ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27906487",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "phylaxis in 22-49%. In addition, monoclonal mast cell activation syndrome has been described presenting with anaphylaxis, especially in patients with ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22744266",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ol subjects. The severity of anaphylaxis was associated with mast cell degranulation, increased plasma heparin levels, the intensity of contact system",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25240785",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " types. Finally, we discuss the possible reasons for the mast cell to utilize compound exocytosis during anaphylaxis, the conflicting evidence in diff",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31011586",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "w clinical entities, such as the \u03b1-gal anaphylaxis. Anaphylaxis results from the massive activation of the mast cells (MCs). Thus, it is also necessar",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/35080312",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ted that mast cell activation and anaphylaxis are negatively regulated by AMP-activated protein kinase (AMPK). However, little is known about the rela",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24948367",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "s not affected. Calcium-independent early activation events in mast cell anaphylaxis indicated on inhibitory influence of PK-treatment. Inhibition of ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2661436",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "phylaxis in 22-49%. In addition, monoclonal mast cell activation syndrome has been described presenting with anaphylaxis, especially in patients with hymenopter",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22744266",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ol subjects. The severity of anaphylaxis was associated with mast cell degranulation, increased plasma heparin levels, the intensity of contact system activation, and bradykin",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25240785",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " types. Finally, we discuss the possible reasons for the mast cell to utilize compound exocytosis during anaphylaxis, the conflicting evidence in different mast cell models, and the open questions in the field which remain to be a",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/31011586",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "arepsilonRI) on mast cells. However, the regulatory mechanism of mast cell activation i",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/20526344",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "s not affected. Calcium-independent early activation events in mast cell anaphylaxis indicated on inhibitory influence ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/2661436",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "r, Ang-1's function in mast cell activation and anaphylaxis diseases is unknown. The results of our study suggest that Ang-1 decreased lipopolysacchar",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24586553",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "\u03b5RI-mediated mast cell activation and anaphylaxis that were insensitive to U0126 or activator 5-aminoimidazole-4-carboxamide-1-\u03b2-4-ribofuranoside, suggesting that the suppression of Fc\u03b5RI signals by the inhibition of the ERK1/2 pathway relies largely on AMPK activation. ERK1/2 controlled AMPK activity by regulating its subcellul",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24948367",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anaphylaxis results from severe systemic mast cell activation. In addition to IgE-mediated and physical triggers, it may occur with a clonal mast cell",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25841551",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "For half a century, it has been known that the mast cell is the cell responsible for the majority of anaphylactic events. Its mediators, taken as a whole, are capable of producing all of the clinical manifestations of these events.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26857018",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anaphylaxis results from severe systemic mast cell activation. In addition to IgE-mediated and physical triggers, it may occur with a clonal mast cell disease and in an idiopathic fashion without clear provoking factors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25841551",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anaphylaxis is a rapidly developing, life-threatening, generalized or systemic allergic reaction that is classically elicited by antigen crosslinking of antigen-specific IgE bound to the high-affinity IgE receptor Fc\u03b5RI on mast cells and basophils.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/27130857",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Anaphylaxis is a rapidly evolving, acute, life-threatening reaction that occurs rapidly on contact with a trigger. Anaphylaxis is classically defined as an allergen-driven process that induces specific IgE and the activation of mast cells and basophils through the cross-linking of IgE receptors.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33832694",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}